EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants

Lingyan Cui, Tingting Li iD, Wenhui Xue, Sibo Zhang, Hong Wang, Hongjing Liu, Ying Gu iD, Ningshao Xia iD, Shaowei Li iD

Viruses · 2024

DOI: 10.3390/v16060900 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Lingyan Cui und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen U…. Hauptthemen laut MEDLINE: SARS-CoV-2, Antibodies, Viral, COVID-19, Broadly Neutralizing Antibodies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, CAMS Innovation Fund for Medical Sciences of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, SARS-CoV-2 has evolved into various variants, including the numerous highly mutated Omicron sub-lineages, significantly increasing immune evasion ability. The development raises concerns about the possibly diminished effectiveness of available vaccines and antibody-based therapeutics. Here, we describe those representative categories of broadly neutralizing antibodies (bnAbs) that retain prominent effectiveness against emerging variants including Omicron sub-lineages. The molecular characteristics, epitope conservation, and resistance mechanisms of these antibodies are further detailed, aiming to offer suggestion or direction for the development of therapeutic antibodies, and facilitate the design of vaccines with broad-spectrum potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Antibodies, ViralCOVID-19Broadly Neutralizing AntibodiesEpitopesSpike Glycoprotein, CoronavirusHumansAntibodies, NeutralizingImmune EvasionCOVID-19 Vaccines

Stichwörter der Autor:innen

SARS-CoV-2 variantsbroadly neutralizing antibodiesepitopesmutations

Substanzen

Antibodies, ViralBroadly Neutralizing AntibodiesEpitopesSpike Glycoprotein, CoronavirusAntibodies, NeutralizingCOVID-19 Vaccinesspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.
  • State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Res…

ORCID-Profile: Tingting Li, Ying Gu, Ningshao Xia, Shaowei Li

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • CAMS Innovation Fund for Medical Sciences of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Cui, L., Li, T., Xue, W., Zhang, S., Wang, H., Liu, H., Gu, Y., Xia, N., & Li, S. (2024). Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants. Viruses. https://doi.org/10.3390/v16060900

Vancouver

Cui L, Li T, Xue W, Zhang S, Wang H, Liu H, et al. Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants. Viruses. 2024. doi:10.3390/v16060900

BibTeX
@article{Cui2024,
  author = {Cui, Lingyan and Li, Tingting and Xue, Wenhui and Zhang, Sibo and Wang, Hong and Liu, Hongjing and Gu, Ying and Xia, Ningshao and Li, Shaowei},
  title = {Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16060900}
}
Kostenlos starten →